Literature DB >> 29635927

Potential and limitations of health policy to improve coronary heart disease prevention and to reduce the burden of disease: A Russian experience.

Nana Pogosova1,2, Rafael Oganov3, Hugo Saner4, Sergey Suvorov2, Olga Sokolova2.   

Abstract

Background Mortality from cardiovascular diseases is particularly high in Russia compared with the European average. The National Priority Project 'Health', launched in 2005, aimed to promote prevention of non-communicable diseases, particularly cardiovascular diseases, in primary care and to increase availability of state-of-art cardiovascular disease management. Methods This is a multiregional population based study with analysis of indicators for cardiovascular health and coronary heart disease in Moscow, St Petersburg, the Moscow region and across Russia, including a total population of 143.7 million inhabitants between 2005 and 2013. Data were collected using conventional methodology and originate from open statistical sources. Results The overall age-standardized coronary heart disease mortality decreased in 2005-2013 by 24.7% from 383.6 to 289.0 per 100000 population, but with substantial interregional differences: it declined from 306.1 to 196.9 per 100,000 in Moscow (-35.7%), from 362.1 to 258.9 per 100,000 in St Petersburg (-28.5%) and from 433.8 to 374.3 per 100,000 in the Moscow region (-13.7%). Income in Moscow exceeded the national average 2-3-fold, and Moscow had the highest availability of modern treatments and interventions. Although vegetables, fruits and fish consumption increased overall in Russia, this trend was most prominent in Moscow. Indicators for psychosocial well-being also were best in Moscow. Life expectancy in Moscow is almost six years higher than the Russian average. Conclusion Health policy interventions turned out to be successful but with substantial interregional differences. Lower coronary heart disease mortality and higher life expectancy in Moscow may be due to a more favourable socioeconomic and psychological environment, more healthy eating and greater availability of medical care.

Entities:  

Keywords:  Coronary heart disease; health policy; morbidity; mortality; prevention; risk factors

Mesh:

Year:  2018        PMID: 29635927     DOI: 10.1177/2047487318768030

Source DB:  PubMed          Journal:  Eur J Prev Cardiol        ISSN: 2047-4873            Impact factor:   7.804


  5 in total

1.  Primary care use and cardiovascular disease risk in Russian 40-69 year olds: a cross-sectional study.

Authors:  Jakob Petersen; Anna Kontsevaya; Martin McKee; Erica Richardson; Sarah Cook; Sofia Malyutina; Alexander V Kudryavtsev; David A Leon
Journal:  J Epidemiol Community Health       Date:  2020-05-04       Impact factor: 3.710

2.  Factors Associated with Anxiety and Depressive Symptoms in 2775 Patients with Arterial Hypertension and Coronary Heart Disease: Results from the COMETA Multicenter Study.

Authors:  Nana Pogosova; Sergey Boytsov; Dirk De Bacquer; Olga Sokolova; Aza Ausheva; Alexander Kursakov; Hugo Saner
Journal:  Glob Heart       Date:  2021-10-19

3.  Primary Exploration of Efficacy of Community-Family Management Mode under Internet-Based Mobile Terminal Monitoring in Elderly Patients with Stable Coronary Heart Disease.

Authors:  Xiang Li; Wenwu Zheng; Jinsong Li; Yibin Gao; Qiang Lin; Jinfeng Yang; Shuiying Huang; Defang Wang; Bin Wang
Journal:  J Healthc Eng       Date:  2022-01-25       Impact factor: 2.682

4.  Physical Rehabilitation Needs in the BRICS Nations from 1990 to 2017: Cross-National Analyses Using Data from the Global Burden of Disease Study.

Authors:  Tiago S Jesus; Michel D Landry; Helen Hoenig; Yi Zeng; Sureshkumar Kamalakannan; Raquel R Britto; Nana Pogosova; Olga Sokolova; Karen Grimmer; Quinette A Louw
Journal:  Int J Environ Res Public Health       Date:  2020-06-10       Impact factor: 3.390

Review 5.  A bibliometric analysis of income and cardiovascular disease: Status, Hotspots, Trends and Outlook.

Authors:  Ye Ding; Dingwan Chen; Xufen Ding; Guan Wang; Yuehua Wan; Qing Shen
Journal:  Medicine (Baltimore)       Date:  2020-08-21       Impact factor: 1.817

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.